Evidence map›Paper›PMID 28085897›Full record

ArticlePloS one2017

Mumps Epidemiology and Mumps Virus Genotypes Circulating in Mainland China during 2013-2015.

Aili Cui, Zhen Zhu, Ying Hu, Xiuying Deng, Zhaodan Sun, Yan Zhang, Naiying Mao, Songtao Xu, Xueqiang Fang, Hui Gao and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Spatial Effect of Ecological Environmental Factors on Mumps in China during 2014-2018.International journal of environmental research and public health · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Aili CuiWHO WPRO Regional Reference Measles/Rubella Laboratory and Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Beijing, People's Republic of China.
Zhen ZhuWHO WPRO Regional Reference Measles/Rubella Laboratory and Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Beijing, People's Republic of China.
Ying HuJiangsu Provincial Centers for Disease Control and Prevention, Nanjing, People's Republic of China.
Xiuying DengJiangsu Provincial Centers for Disease Control and Prevention, Nanjing, People's Republic of China.
Zhaodan SunHeilongjiang Provincial Centers for Disease Control and Prevention, Ha'erbin, People's Republic of China.
Yan ZhangWHO WPRO Regional Reference Measles/Rubella Laboratory and Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Beijing, People's Republic of China.
Naiying MaoWHO WPRO Regional Reference Measles/Rubella Laboratory and Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Beijing, People's Republic of China.
Songtao XuWHO WPRO Regional Reference Measles/Rubella Laboratory and Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Beijing, People's Republic of China.
Xueqiang FangShandong Provincial Centers for Disease Control and Prevention, Jinan, People's Republic of China.
Hui GaoShanxi Provincial Centers for Disease Control and Prevention, Taiyuan, People's Republic of China.
Yuan SiShannxi Provincial Centers for Disease Control and Prevention, Xi'an, People's Republic of China.
Yake LeiHubei Provincial Centers for Disease Control and Prevention, Wuhan, People's Republic of China.
Huanying ZhengGuangdong Provincial Centers for Disease Control and Prevention, Guangzhou, People's Republic of China.
Jilan HeSichuan Provincial Centers for Disease Control and Prevention, Chengdu, People's Republic of China.
Hongwei WuAffiliated hospital of Beihua University, Jilin, People's Republic of China.
Wenbo XuWHO WPRO Regional Reference Measles/Rubella Laboratory and Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Beijing, People's Republic of China.
National Institute for Viral Disease Control and Prevention · CNJiangsu Provincial Center for Disease Control and Prevention · CNBeihua University · CNGuangdong Provincial Center for Disease Control and Prevention · CNHubei Provincial Center for Disease Control and Prevention · CNShandong Center for Disease Control and Prevention · CNSichuan Center for Disease Control and Prevention · CNXian Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the implementation of mumps virus (MuV) vaccination in the expanded program on immunization (EPI) in mainland China since 2008, the incidence of mumps has decreased, and the natural epidemic pattern of mumps has slightly changed during 2013-2015. The two epidemic peaks (April-July and November-December) became less obvious than those observed from 2004 to 2012. Children and adolescents younger than 15, particularly in the five-to-nine-year-old age group, remain the target group and should be the focus of high-quality immunization activities in mainland China. However, it was also found that the incidence and reported cases of mumps decreased in each age group during 2013-2015, particularly in the five-to-nine-year-old and ten-to-fourteen-year-old age groups. The proportion of mumps cases among adults in some provinces also increased. Unlike the changes in the epidemiological characteristics of mumps affected by vaccination, the data of MuV virology surveillance indicated that most of the MuV transmission chains have not yet been effectively interrupted, and MuV remains a natural epidemic pattern in mainland China. In the MuV virology surveillance, 194 MuV strains during 2013-2015 were isolated from 10 of 31 provinces in mainland China. Based on the phylogenetic analysis of the small hydrophobic (SH) gene, both genotype F (99.0%) and G (1.0%) were identified, and genotype F was still the predominant genotype continuously circulating in mainland China. Representative genotype F and G strains isolated in China from 1995 to 2012 were selected for further analysis. The results indicated that there were multiple transmission chains within genotype F, with no obvious geographical or time differences. The high genetic diversity of genotype F strains could be a result of the continuous transmission and evolution of the MuV in mainland China. Genotype G was also detected in four provinces in mainland China. Because of the limited epidemiological data, it was uncertain whether the genotype G MuV strains found in 2011 and 2013 were imported from other countries. Therefore, combined high-quality epidemiological and virological surveillance is necessary for mumps control; it can also be used to observe the changes in epidemiological characteristics and viral transmission of mumps over time after mumps-containing vaccine (MuCV) implementation and to provide a comprehensive epidemiological and genetic baseline for mumps elimination in mainland China.

Indexed as

AdolescentAdultChildChild, PreschoolChinaGenotypeHumansInfantInfant, NewbornMumpsMumps virusPhylogenyRNA, ViralTime FactorsViral ProteinsYoung AdultRNA, ViralViral Proteins

Identifiers

PMID28085897
PMCPMC5234798
OpenAlexW2571892062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.